Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Jan-Erik Damber

Professor

Jan-Erik Damber
Professor
jan-erik.damber@urology.gu.se

Postal Address: Sahlgrenska universitetssjukhuset, 41345 Göteborg
Visiting Address: Bruna stråket 11b v 2 su/sahlgrenska , 41345 Göteborg


Department of Urology at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
0313424145
Visiting Address: Bruna stråket 11b V 2 SU/Sahlgrenska , 413 45 Göteborg

Latest publications

Androgen deprivation therapy for prostate cancer and risk of dementia
D. Robinson, H. Garmo, M. Van Hemelrijck, Jan-Erik Damber, Ola Bratt et al.
Bju International, Journal article 2019
Journal article

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Matthew R Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris A Hadaschik et al.
The New England journal of medicine, Journal article 2018
Journal article

Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen-deprivation therapy for hormone-naïve bone-metastatic prostate cancer.
Maria Ebbinge, Anders Berglund, Eberhard Varenhorst, Per Olov Hedlund, Gabriel Sandblom et al.
BJU international, Journal article 2018
Journal article

Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer
S. Loeb, Y. Folkvaljon, Jan-Erik Damber, J. Alukal, M. Lambe et al.
Journal of Clinical Oncology, Journal article 2017
Journal article

Showing 1 - 10 of 123

2019

Androgen deprivation therapy for prostate cancer and risk of dementia
D. Robinson, H. Garmo, M. Van Hemelrijck, Jan-Erik Damber, Ola Bratt et al.
Bju International, Journal article 2019
Journal article

2018

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Matthew R Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris A Hadaschik et al.
The New England journal of medicine, Journal article 2018
Journal article

Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen-deprivation therapy for hormone-naïve bone-metastatic prostate cancer.
Maria Ebbinge, Anders Berglund, Eberhard Varenhorst, Per Olov Hedlund, Gabriel Sandblom et al.
BJU international, Journal article 2018
Journal article

2017

Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer
S. Loeb, Y. Folkvaljon, Jan-Erik Damber, J. Alukal, M. Lambe et al.
Journal of Clinical Oncology, Journal article 2017
Journal article

Showing 1 - 10 of 123

Page Manager: Katarina Olinder Eriksson|Last update: 1/7/2014
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?